Subcutaneous appearance of a centrocytic Non-Hodgkin lymphoma at the site of injection of a mistletoe preparation;Subkutane manifestationen eines zentrozytischen Non-Hodgkin-lymphoms an injektionsstellen eines mistelpraparats

Deutsche Medizinische Wochenschrift

Volumn 123, Issue 34-35, 1998, Pages 1001-1004

  Hagenah, W ^a   Dorges I ^a   Gafumbegete, E ^a   Wagner, T ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL WALL; AGED; ARTICLE; CANCER LOCALIZATION; CASE REPORT; CERVICAL LYMPH NODE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; INJECTION SITE; LYMPH NODE BIOPSY; LYMPHADENOPATHY; MALE; NONHODGKIN LYMPHOMA; VISCUM ALBUM;

EID: 0032555411     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1024111     Document Type: Article

References (18)

1. Beuth, J., H. L. Ko, H.-J. Gabius, G. Pulverer: Influence of treatment with the immunmodulatory effective dose of the β-galactoside-specific lectin from mistletoe on tumor colonization in BALB/c-mice for two experimental mode systems. In Vivo 5 (1991), 29-32.
2. Beuth, E., H. L. Ko, L. Tunggal, H.-J. Gabius, M. Steuer, G. Uhlenbruck, G. Pulverer: Das Lektin der Mistel in der adjuvanten Therapie beim Mammakarzinom - erste klinische Erfahrungen. Med. Welt 44 (1993), 217-220.
3. Bocci, V.: Mistletoe (viscum album) lectins as cytokine inducers and immunadjuvant in tumor therapy. A review. J. biol. Regulat. homeostat. Agents 7 (1993), 1-6.
4. Bussing, A., K. Suzart, J. Bergmann, U. Pfuller, M. Schietzel, K. Schweitzer: Induction of apoptosis in human lymphocytes treated with Viscum album L. is mediated by the mistletoes lectins. Cancer Lett. 99 (1996), 59-72.
5. Franz, H.: Mistletoe lectins and their A and B chains. Oncology 43 (Suppl.) (1986), 23-34.
6. Hajto, T., K. Hotstanska, K. Frei, C. Rordorf, H.-J. Gabius: Increased secretion of TNF-α, IL-1 and IL-6 by human mononuclear cells exposed to β-galactoside-specific lectin from clinically applied mistletoe extract. Cancer Res. 50 (1990), 3322-3326.
7. Joller, P. W., J. M. Menrad, T. Schwarz, U. Pfuller, M. J. Parnham, R. Weyhenmeyer, H. Lentzen: Stimulation of cytokine production via a special standardized mistletoe preparation in an in vitro human skin bioassay. Arzneimittel-Forsch./Drug Res. 46 (I) (1996), 649-653.
8. Katz, A., L. M. Shulman, A. Porgador, M. Revel, M. Feldmann, L. Eisenbach: Abrogation of B16 melanoma metastases by long-term low-dose interleukin-6 therapy. J. Immunother. 13 (1993), 98-109.
9. Kawano, M., T. Hirano, T. Matsuda, T. Taga, Y. Horii, K. Iwato, H. Asaoku, B. Tang, O. Tanabe, H. Tanaka, A. Kuramoto, T. Kishimoto: Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 332 (1988), 83-85.
10. Klein, B., X. Zhang, M. Jourdan, J. Content, F. Houssiau, L. Aarden, M. Piechaczyk, R. Bataille: Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. Blood 73 (1989), 517-526.
11. Mueller, E. A., F. A. Anderer: A viscum album oligosaccharide activating human natural cytotoxicity is an interferon-γ inducer. Cancer Immunol. Immunther. 32 (1990), 221-227.
12. Mullen, C. A., M. M. Coale, A. T. Levy, W. G. Stetler-Stevenson, L. A. Liotta, S. Brandt, R. M. Blaese: Fibrosarcoma cells transduced with the IL-6 gene exhibit reduced tumorigenicity, increased immunogenicity, and decreased metastatic potential. Cancer Res. 52 (1992), 6020-6024.
13. Porgador, A., E. Tzehoval, A. Katz, E. Vadai, M. Feldmann, L. Eisenbach: Interleukin-6 gene transfection into Lewis lung carcinoma tumor cells suppresses the malignant phenotype and confers immunotherapeutic competence against parental metastatic cells. Cancer Res. 52 (1992), 3679-3686.
14. Stein, G. M., H. Meink, J. Durst, P. A. Berg: Release of cytokines by a fermented lectin-1 (ML-1) free mistletoe extract reflects differences in the reactivity of PBMC in healthy and allergic individuals and tumor patients. Europ. J. clin. Pharmacol. 51 (1996), 247-252.
15. Sun, W. H., A. Kreisle, A. W. Phillips, W. B. Ershler: In vivo and in vitro characteristics of interleukin-6-transfected B 16 melanoma cells. Cancer Res. 52 (1992), 5412-5415.
16. 2 (BSF-2, IL-6). Science 239 (1988), 502-504.
17. Tosato, G., T. L. Gerrad, N. G. Goldmann, S. E. Pike: Stimulation of EBV-activated human B cells by monocytes and monocytes products. Role of IFN-beta 2/B cell stimulatory factor 2/1L-6. J. Immunol. 140 (1988), 4329-4336.
18. Wenzel-Seifert, K., H. Lentzen, R. Seifert: In U-937 promonocytes, mistletoe lectin I increases basal [Ca2+]i, enhances histamine H1-and complement C5a-receptor-mediated rises in [Ca2+]i, and induces cell death. Naunyn-Schmiedeberg's Arch. Pharmacol. 355 (1997), 190-197.